Success Rate, Continence, and Quality of Life With a Bioprosthetic Plug for Treating Complex Anal Fistula
Primary Purpose
Complex Anal Fistula
Status
Completed
Phase
Phase 2
Locations
Switzerland
Study Type
Interventional
Intervention
Anal fistula plug
Sponsored by
About this trial
This is an interventional treatment trial for Complex Anal Fistula focused on measuring anal fistula, anal continence, health-related quality of life
Eligibility Criteria
Inclusion Criteria:
Complex anal fistula as defined by
- high transsphincteric fistula
- extrasphincteric fistula
- suprasphincteric fistula
- recurrent fistula
- multiple fistula openings, including horseshoe fistula
- imperfect continence- jeopardized anal continence (anterior transsphincteric fistula, prior anal surgery)
Exclusion Criteria:
- Uncomplicated fistula curable by simple fistulotomy
- History of inflammatory bowel disease
- Chronic immunosuppressive treatment (ie, systemic steroids for >3 days)
- Clinical heart failure as defined by a CCS angina severity class ≥ III
- Untreated cancer or cancer diagnosed/treated (all modalities) within 6 months
- Estimated life expectancy inferior to 6 months
- Incompetent subject
- Pregnancy
Sites / Locations
- University of Basel & Kantonsspital St.Gallen
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Anal fistula plug
Arm Description
Outcomes
Primary Outcome Measures
Fistula healing
Clinical healing of a complex anal fistula as assessed in the clinic at 6 weeks and 6 months after anal fistula plug surgery. Further assessment prn.
Anal continence
Evaluation of anal continence by means of a validated questionnaire, namely the Fecal Incontinence Severity Index, at 6 weeks and 6 months after anal fistula plug surgery.
Quality of life
Evaluation of health-related quality of life by means of a validated questionnaire, namely the Short-Form 36 version 2, at 6 weeks and 6 months after anal fistula plug surgery.
Secondary Outcome Measures
Full Information
NCT ID
NCT01612195
First Posted
June 2, 2012
Last Updated
May 16, 2013
Sponsor
University Hospital, Basel, Switzerland
Collaborators
Unity Health Toronto, Women's College Hospital, St. Claraspital AG, Mount Sinai Hospital, Canada
1. Study Identification
Unique Protocol Identification Number
NCT01612195
Brief Title
Success Rate, Continence, and Quality of Life With a Bioprosthetic Plug for Treating Complex Anal Fistula
Official Title
Success Rate, Continence, and Quality of Life With a Bioprosthetic Plug for Treating Complex Anal Fistula
Study Type
Interventional
2. Study Status
Record Verification Date
May 2013
Overall Recruitment Status
Completed
Study Start Date
January 2007 (undefined)
Primary Completion Date
March 2009 (Actual)
Study Completion Date
January 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Basel, Switzerland
Collaborators
Unity Health Toronto, Women's College Hospital, St. Claraspital AG, Mount Sinai Hospital, Canada
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Anal abscess-fistula disease is of common occurrence and has a significant impact on the quality of life of affected individuals. The course of abscess-fistula disease as well as its treatment modalities may affect anal continence. The present cohort study investigates the results of anal fistula plug surgery. In particular, this study focus on the impact of anal fistula plug surgery on fistula healing, quality of life, and anal continence. Fifty patients will be included and followed up at 6 weeks and 6 months after surgery in the clinic of participating surgeons.
Detailed Description
Anal abscess-fistula disease is of common occurrence and has a significant impact on the quality of life of affected individuals. The clinical course of abscess-fistula disease as well as its treatment modalities may affect anal continence. Anal fistula plug surgery is an Health Canada and FDA approved surgical treatment that has demonstrated promising results in terms of fistula healing and minimal patients' burden. The present cohort study prospectively investigates the results of anal fistula plug surgery performed in teaching hospitals affiliated to the University of Toronto. In particular, this study focus on the impact of anal fistula plug surgery on health-related quality of life, and its 2 major determinants anal continence and fistula healing. Fifty patients will be included and followed up at 6 weeks and 6 months after surgery in the clinic of participating surgeons. Quality of life and anal continence will be measured with the validated Short Form-36 Health Survey (SF-36 v2) and Fecal Incontinence Score Index (FISI) questionnaires, respectively. It is expected that the present study will provide objective information on the results and generalizability of anal fistula surgery, as well as on its impact on health-related quality of life and anal continence.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Complex Anal Fistula
Keywords
anal fistula, anal continence, health-related quality of life
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
46 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Anal fistula plug
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
Anal fistula plug
Other Intervention Name(s)
Anal fistula plug Surgisis®
Intervention Description
All patients have a draining seton for at least 6 weeks prior placement of the anal fistula plug. All patients are administered a general anesthetic and are operated in the lithotomy position. The seton is removed, but no curettage or irrigation of the fistula tract is performed. The plug is inserted through the internal opening, and pulled through the external opening until it fit snugly and its base is sutured to the internal sphincter with 2 interrupted 2-0 polyglactin 910 sutures. The tip of the plug is cut at skin level and not sutured. The external opening is left open to allow for drainage. The patient is instructed to restrict physical and sexual activity for 2 weeks postoperatively. Patients are seen in the post-operative clinic at 10 days, 6 weeks and 6 months as per protocol.
Primary Outcome Measure Information:
Title
Fistula healing
Description
Clinical healing of a complex anal fistula as assessed in the clinic at 6 weeks and 6 months after anal fistula plug surgery. Further assessment prn.
Time Frame
6 months
Title
Anal continence
Description
Evaluation of anal continence by means of a validated questionnaire, namely the Fecal Incontinence Severity Index, at 6 weeks and 6 months after anal fistula plug surgery.
Time Frame
6 months
Title
Quality of life
Description
Evaluation of health-related quality of life by means of a validated questionnaire, namely the Short-Form 36 version 2, at 6 weeks and 6 months after anal fistula plug surgery.
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Complex anal fistula as defined by
high transsphincteric fistula
extrasphincteric fistula
suprasphincteric fistula
recurrent fistula
multiple fistula openings, including horseshoe fistula
imperfect continence- jeopardized anal continence (anterior transsphincteric fistula, prior anal surgery)
Exclusion Criteria:
Uncomplicated fistula curable by simple fistulotomy
History of inflammatory bowel disease
Chronic immunosuppressive treatment (ie, systemic steroids for >3 days)
Clinical heart failure as defined by a CCS angina severity class ≥ III
Untreated cancer or cancer diagnosed/treated (all modalities) within 6 months
Estimated life expectancy inferior to 6 months
Incompetent subject
Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michel Adamina, MD, PD, MSc
Organizational Affiliation
University of Basel
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Basel & Kantonsspital St.Gallen
City
Basel & St.Gallen
ZIP/Postal Code
4031 & 9007
Country
Switzerland
12. IPD Sharing Statement
Learn more about this trial
Success Rate, Continence, and Quality of Life With a Bioprosthetic Plug for Treating Complex Anal Fistula
We'll reach out to this number within 24 hrs